Bristol-myers Squibb recalls
FDA enforcement reports naming Bristol-myers Squibb Company as the recalling firm.
- Recall reports
- 5
- Class I (serious)
- 2
- Most recent report
- Oct 29, 2025
- Oct 29, 2025Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4m…Drug · Bristol-Myers Squibb CompanyLack of Assurance of Sterility.Class II
- Jul 19, 2017EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Compan…Drug · Bristol-myers Squibb CompanyLabeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.Class I
- Oct 31, 2012Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sampl…Drug · Bristol-myers Squibb CompanyLabeling; Correct labeled product miscart/mispack: Some Physician sample cartons were incorrectly labeled as Kombiglyze XR 2.5mg/1000mg on the external package carton, whereas the contents were Kombiglyze XR 5 mg/500 mg…Class II
- Oct 31, 2012Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sampl…Drug · Bristol-myers Squibb CompanyLabeling; Correct labeled product miscart/mispack: Some Physician sample cartons were incorrectly labeled as Kombiglyze XR 2.5mg/1000mg on the external package carton, whereas the contents were Kombiglyze XR 5 mg/500 mg…Class II
- Oct 31, 2012BiCNU (Carmustine for injection) 100 mg and Diluent Rx Only BiCNU manufactured by: Be…Drug · Bristol-myers Squibb CompanySuperpotent (Single Ingredient) Drug: All BiCNU lots within expiration which contain carmustine vial lots manufactured by BenVenue Laboratories (BVL) are being recalled because of an overfilled vial discovered during st…Class I